Merck Acquires Caraway to Strengthen Focus on Neurodegenerative Diseases
- Posted by ISPE Boston
- On December 7, 2023
Cambridge-based Caraway Therapeutics has agreed to be acquired by pharma giant Merck for a total potential consideration of up to $610 million. Caraway describes itself as a leader in the cutting-edge science of activating cellular recycling processes to clear toxic materials and defective cellular components by modulating lysosomal function and is utilizing its unique product […]
Read More